Papers of particular interest, published recently, have been highlighted as:
·Of importance
··Of outstanding importance
1. Flegal KM, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307(5):491–7. [PubMed] [Google Scholar]
2. Olson AL, Zwillich C. The obesity hypoventilation syndrome. Am J Med. 2005;118(9):948–56. [PubMed] [Google Scholar]
3. Mokhlesi B, Kryger MH, Grunstein RR. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc. 2008;5(2):218–25. [PMC free article] [PubMed] [Google Scholar]
4. Mokhlesi B, Tulaimat A. Recent advances in obesity hypoventilation syndrome. Chest. 2007;132(4):1322–36. [PubMed] [Google Scholar]
5. Mokhlesi B, et al. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath. 2007;11(2):117–24. [PubMed] [Google Scholar]
6. Mokhlesi B. Obesity hypoventilation syndrome: a state-of-the-art review. Respir Care. 2010;55(10):1347–62. discussion 1363–5. [PubMed] [Google Scholar]
7. Bulbul Y, et al. Frequency and predictors of obesity hypoventilation in hospitalized patients at a tertiary health care institution. Ann Thorac Med. 2014;9(2):87–91. [PMC free article] [PubMed] [Google Scholar]
8. Kaw R, et al. Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies. Chest. 2009;136(3):787–96. [PubMed] [Google Scholar]
9. Nowbar S, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med. 2004;116(1):1–7. [PubMed] [Google Scholar]
10. Resta O, et al. Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnoea. Respir Med. 2000;94(3):240–6. [PubMed] [Google Scholar]
11. Trakada GP, et al. Prevalence and clinical characteristics of obesity hypoventilation syndrome among individuals reporting sleep-related breathing symptoms in northern Greece. Sleep Breath. 2010;14(4):381–6. [PubMed] [Google Scholar]
12. Verin E, Tardif C, Pasquis P. Prevalence of daytime hypercapnia or hypoxia in patients with OSAS and normal lung function. Respir Med. 2001;95(8):693–6. [PubMed] [Google Scholar]
13. Akashiba T, et al. Clinical characteristics of obesity-hypoventilation syndrome in Japan: a multi-center study. Intern Med. 2006;45(20):1121–5. [PubMed] [Google Scholar]
14. Golpe R, Jimenez A, Carpizo R. Diurnal hypercapnia in patients with obstructive sleep apnea syndrome. Chest. 2002;122(3):1100–1. author reply 1101. [PubMed] [Google Scholar]
15. Laaban JP, Chailleux E. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest. 2005;127(3):710–5. [PubMed] [Google Scholar]
16. Hart N, et al. Obesity hypoventilation syndrome: does the current definition need revisiting? Thorax. 2014;69(1):83–4. [PubMed] [Google Scholar]
17. Polotsky M, et al. Effects of leptin and obesity on the upper airway function. J Appl Physiol (1985) 2012;112(10):1637–43. [PMC free article] [PubMed] [Google Scholar]
18. Rapoport DM, et al. Hypercapnia in the obstructive sleep apnea syndrome. A reevaluation of the “Pickwickian syndrome” Chest. 1986;89(5):627–35. [PubMed] [Google Scholar]
19. Kress JP, et al. The impact of morbid obesity on oxygen cost of breathing (VO(2RESP)) at rest. Am J Respir Crit Care Med. 1999;160(3):883–6. [PubMed] [Google Scholar]
20. Resta O, et al. Hypercapnia in obstructive sleep apnoea syndrome. Neth J Med. 2000;56(6):215–22. [PubMed] [Google Scholar]
21. Piper AJ. Obesity hypoventilation syndrome–the big and the breathless. Sleep Med Rev. 2011;15(2):79–89. [PubMed] [Google Scholar]
22. Behazin N, et al. Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity. J Appl Physiol (1985) 2010;108(1):212–8. [PMC free article] [PubMed] [Google Scholar]
23. Naimark A, Cherniack RM. Compliance of the respiratory system and its components in health and obesity. J Appl Physiol. 1960;15:377–82. [PubMed] [Google Scholar]
24. Pelosi P, et al. Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients. Chest. 1996;109(1):144–51. [PubMed] [Google Scholar]
25. Zerah F, et al. Effects of obesity on respiratory resistance. Chest. 1993;103(5):1470–6. [PubMed] [Google Scholar]
26. Sharp JT, et al. The Total Work of Breathing in Normal and Obese Men. J Clin Invest. 1964;43:728–39. [PMC free article] [PubMed] [Google Scholar]
27. Pankow W, et al. Expiratory flow limitation and intrinsic positive end-expiratory pressure in obesity. J Appl Physiol (1985) 1998;85(4):1236–43. [PubMed] [Google Scholar]
28. Steier J, et al. Neural respiratory drive in obesity. Thorax. 2009;64(8):719–25. [PubMed] [Google Scholar]
29. Yap JC, et al. Effects of posture on respiratory mechanics in obesity. J Appl Physiol (1985) 1995;79(4):1199–205. [PubMed] [Google Scholar]
30. Ferretti A, et al. Expiratory flow limitation and orthopnea in massively obese subjects. Chest. 2001;119(5):1401–8. [PubMed] [Google Scholar]
31. Lee MY, et al. Work of breathing in eucapnic and hypercapnic sleep apnea syndrome. Respiration. 2009;77(2):146–53. [PubMed] [Google Scholar]
32. Lin CC, et al. Oral airway resistance during wakefulness in eucapnic and hypercapnic sleep apnea syndrome. Respir Physiol Neurobiol. 2004;139(2):215–24. [PubMed] [Google Scholar]
33. Chlif M, et al. Effects of obesity on breathing pattern, ventilatory neural drive and mechanics. Respir Physiol Neurobiol. 2009;168(3):198–202. [PubMed] [Google Scholar]
34. Pankow W, et al. Influence of noninvasive positive pressure ventilation on inspiratory muscle activity in obese subjects. Eur Respir J. 1997;10(12):2847–52. [PubMed] [Google Scholar]
35. Sampson MG, Grassino AE. Load compensation in obese patients during quiet tidal breathing. J Appl Physiol Respir Environ Exerc Physiol. 1983;55(4):1269–76. [PubMed] [Google Scholar]
36. Kessler R, et al. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest. 2001;120(2):369–76. [PubMed] [Google Scholar]
37. Berg G, et al. The use of health-care resources in obesity-hypoventilation syndrome. Chest. 2001;120(2):377–83. [PubMed] [Google Scholar]
38. Borel JC, et al. Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome. PLoS One. 2009;4(8):e6733. [PMC free article] [PubMed] [Google Scholar]
39. Masa JF, et al. Noninvasive positive pressure ventilation and not oxygen may prevent overt ventilatory failure in patients with chest wall diseases. Chest. 1997;112(1):207–13. [PubMed] [Google Scholar]
40. Rochester DF, Enson Y. Current concepts in the pathogenesis of the obesity-hypoventilation syndrome. Mechanical and circulatory factors. Am J Med. 1974;57(3):402–20. [PubMed] [Google Scholar]
41. Sharp JT, Druz WS, Kondragunta VR. Diaphragmatic responses to body position changes in obese patients with obstructive sleep apnea. Am Rev Respir Dis. 1986;133(1):32–7. [PubMed] [Google Scholar]
42. Jonville S, Delpech N, Denjean A. Contribution of respiratory acidosis to diaphragmatic fatigue at exercise. Eur Respir J. 2002;19(6):1079–86. [PubMed] [Google Scholar]
43. Monneret D, et al. Pleiotropic role of IGF-I in obesity hypoventilation syndrome. Growth Horm IGF Res. 2010;20(2):127–33. [PubMed] [Google Scholar]
44. BaHammam A. Acute ventilatory failure complicating obesity hypoventilation: update on a ‘critical care syndrome’ Curr Opin Pulm Med. 2010;16(6):543–51. [PubMed] [Google Scholar]
45. Sampson MG, Grassino K. Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am J Med. 1983;75(1):81–90. [PubMed] [Google Scholar]
46. Lopata M, Onal E. Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis. 1982;126(4):640–5. [PubMed] [Google Scholar]
47. Macavei VM, et al. Diagnostic predictors of obesity-hypoventilation syndrome in patients suspected of having sleep disordered breathing. J Clin Sleep Med. 2013;9(9):879–84. [PMC free article] [PubMed] [Google Scholar]
48. Zwillich CW, et al. Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome. Am J Med. 1975;59(3):343–8. [PubMed] [Google Scholar]
49. Lin CC. Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnoea syndrome. Eur Respir J. 1994;7(11):2005–10. [PubMed] [Google Scholar]
50. de Lucas-Ramos P, et al. Benefits at 1 year of nocturnal intermittent positive pressure ventilation in patients with obesity-hypoventi lation syndrome. Respir Med. 2004;98(10):961–7. [PubMed] [Google Scholar]
51. Berthon-Jones M, Sullivan CE. Time course of change in ventilatory response to CO2 with long-term CPAP therapy for obstructive sleep apnea. Am Rev Respir Dis. 1987;135(1):144–7. [PubMed] [Google Scholar]
52. Han F, et al. Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea-hypopnea syndrome. Chest. 2001;119(6):1814–9. [PubMed] [Google Scholar]
53. Jones RL, Nzekwu MM. The effects of body mass index on lung volumes. Chest. 2006;130(3):827–33. [PubMed] [Google Scholar]
54. Berger KI, et al. Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest. 2001;120(4):1231–8. [PubMed] [Google Scholar]
55. Caro JF, et al. Leptin: the tale of an obesity gene. Diabetes. 1996;45(11):1455–62. [PubMed] [Google Scholar]
56. Phipps PR, et al. Association of serum leptin with hypoventilation in human obesity. Thorax. 2002;57(1):75–6. [PMC free article] [PubMed] [Google Scholar]
57. Shimura R, et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127(2):543–9. [PubMed] [Google Scholar]
58. Tatsumi K, et al. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127(3):716–21. [PubMed] [Google Scholar]
59. O’Donnell CP, et al. Leptin, obesity, and respiratory function. Respir Physiol. 2000;119(2–3):163–70. [PubMed] [Google Scholar]
60. Campo A, et al. Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J. 2007;30(2):223–31. [PubMed] [Google Scholar]
61. Tankersley CG, et al. Leptin attenuates respiratory complications associated with the obese phenotype. J Appl Physiol (1985) 1998;85(6):2261–9. [PubMed] [Google Scholar]
62. Huang K, et al. Effects of leptin deficiency on postnatal lung development in mice. J Appl Physiol (1985) 2008;105(1):249–59. [PMC free article] [PubMed] [Google Scholar]
63. Basoglu OK, Tasbakan MS. Comparison of clinical characteristics in patients with obesity hypoventilation syndrome and obese obstructive sleep apnea syndrome: a case-control study. Clin Respir J. 2014;8(2):167–74. [PubMed] [Google Scholar]
64. Manuel AR, Hart N, Stradling JR. Is a raised bicarbonate, without hypercapnia, part of the physiological spectrum of obesity-related hypoventilation? Chest. 2014 [PubMed] [Google Scholar]
65. Combs D, Shetty S, Parthasarathy S. Advances in Positive Airway Pressure Treatment Modalities for Hypoventilation Syndromes. Sleep Med Clin. 2014;9(3):315–325. [PMC free article] [PubMed] [Google Scholar]
66. Carrillo A, et al. Noninvasive ventilation in acute hypercapnic respiratory failure caused by obesity hypoventilation syndrome and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(12):1279–85. [PubMed] [Google Scholar]
67. Kelly JL, et al. Randomized trial of ‘intelligent’ autotitrating ventilation versus standard pressure support non-invasive ventilation: impact on adherence and physiological outcomes. Respirology. 2014;19(4):596–603. [PubMed] [Google Scholar]
68. Held M, et al. Functional impact of pulmonary hypertension due to hypoventilation and changes under noninvasive ventilation. Eur Respir J. 2014;43(1):156–65. [PubMed] [Google Scholar]
69. Kawata N, et al. Daytime hypercapnia in obstructive sleep apnea syndrome. Chest. 2007;132(6):1832–8. [PubMed] [Google Scholar]
70. Piper AJ, et al. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax. 2008;63(5):395–401. [PubMed] [Google Scholar]
71. Hida W, et al. Nasal continuous positive airway pressure improves quality of life in obesity hypoventilation syndrome. Sleep Breath. 2003;7(1):3–12. [PubMed] [Google Scholar]
72. Banerjee D, et al. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest. 2007;131(6):1678–84. [PubMed] [Google Scholar]
73. Salord N, et al. Continuous positive airway pressure in clinically stable patients with mild-to-moderate obesity hypoventilation syndrome and obstructive sleep apnoea. Respirology. 2013;18(7):1135–42. [PubMed] [Google Scholar]
74. Janssens JP, et al. Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. Chest. 2003;123(1):67–79. [PubMed] [Google Scholar]
75. Masa JF, et al. The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation. Chest. 2001;119(4):1102–7. [PubMed] [Google Scholar]
76. Perez de Llano LA, et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest. 2005;128(2):587–94. [PubMed] [Google Scholar]
77. Priou P, et al. Long-term outcome of noninvasive positive pressure ventilation for obesity hypoventilation syndrome. Chest. 2010;138(1):84–90. [PubMed] [Google Scholar]
78. Chouri-Pontarollo N, et al. Impaired objective daytime vigilance in obesity-hypoventilation syndrome: impact of noninvasive ventilation. Chest. 2007;131(1):148–55. [PubMed] [Google Scholar]
79. Storre JH, et al. Average volume-assured pressure support in obesity hypoventilation: A randomized crossover trial. Chest. 2006;130(3):815–21. [PubMed] [Google Scholar]
80. Redolfi S, et al. Long-term non-invasive ventilation increases chemosensitivity and leptin in obesity-hypoventilation syndrome. Respir Med. 2007;101(6):1191–5. [PubMed] [Google Scholar]
81. Windisch W, g. Quality of life in home mechanical ventilation study Impact of home mechanical ventilation on health-related quality of life. Eur Respir J. 2008;32(5):1328–36. [PubMed] [Google Scholar]
82. Borel JC, et al. Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest. 2012;141(3):692–702. [PubMed] [Google Scholar]
83. Rabec C, et al. Ventilator modes and settings during non-invasive ventilation: effects on respiratory events and implications for their identification. Thorax. 2011;66(2):170–8. [PubMed] [Google Scholar]
84. Berry RB, et al. Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes. J Clin Sleep Med. 2010;6(5):491–509. [PMC free article] [PubMed] [Google Scholar]
85. Contal O, et al. Impact of different backup respiratory rates on the efficacy of noninvasive positive pressure ventilation in obesity hypoventilation syndrome: a randomized trial. Chest. 2013;143(1):37–46. [PubMed] [Google Scholar]
86. Chirinos JA, et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med. 2014;370(24):2265–75. [PMC free article] [PubMed] [Google Scholar]
87. Ambrogio C, et al. Sleep and non-invasive ventilation in patients with chronic respiratory insufficiency. Intensive Care Med. 2009;35(2):306–13. [PubMed] [Google Scholar]
88. Amato MB, et al. Volume-assured pressure support ventilation (VAPSV). A new approach for reducing muscle workload during acute respiratory failure. Chest. 1992;102(4):1225–34. [PubMed] [Google Scholar]
89. Murphy PB, et al. Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax. 2012;67(8):727–34. [PubMed] [Google Scholar]
90. Hollier CA, et al. Moderate concentrations of supplemental oxygen worsen hypercapnia in obesity hypoventilation syndrome: a randomised crossover study. Thorax. 2014;69(4):346–53. [PubMed] [Google Scholar]
91. Wijesinghe M, et al. The effect of supplemental oxygen on hypercapnia in subjects with obesity-associated hypoventilation: a randomized, crossover, clinical study. Chest. 2011;139(5):1018–24. [PubMed] [Google Scholar]
92. Mokhlesi B, Tulaimat A, Parthasarathy S. Oxygen for obesity hypoventilation syndrome: a double-edged sword? Chest. 2011;139(5):975–7. [PubMed] [Google Scholar]
93. Heinemann F, et al. Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome. Respir Med. 2007;101(6):1229–35. [PubMed] [Google Scholar]
94. Budweiser S, et al. Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation. J Intern Med. 2007;261(4):375–83. [PubMed] [Google Scholar]
95. Hawrylkiewicz I, et al. Pulmonary haemodynamics in patients with OSAS or an overlap syndrome. Monaldi Arch Chest Dis. 2004;61(3):148–52. [PubMed] [Google Scholar]
96. Chaouat A, et al. Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia. Eur Respir J. 1997;10(8):1730–5. [PubMed] [Google Scholar]
97. Fletcher EC, et al. Exercise hemodynamics and gas exchange in patients with chronic obstruction pulmonary disease, sleep desaturation, and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis. 1989;140(5):1237–45. [PubMed] [Google Scholar]
98. Castro-Anon O, et al. Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome. Respirology. 2012;17(8):1269–74. [PubMed] [Google Scholar]
99. Masa Jimenez JF, et al. Nasal intermittent positive pressure ventilation. Analysis of its withdrawal. Chest. 1995;107(2):382–8. [PubMed] [Google Scholar]
100. De Miguel Diez J, et al. Analysis of withdrawal from noninvasive mechanical ventilation in patients with obesity-hypoventilation syndrome. Medium term results. Arch Bronconeumol. 2003;39(7):292–7. [PubMed] [Google Scholar]
101. McArdle N, et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159(4 Pt 1):1108–14. [PubMed] [Google Scholar]
102. Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS) Sleep Med Rev. 2003;7(1):81–99. [PubMed] [Google Scholar]
103. Mokhlesi B, et al. Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. J Clin Sleep Med. 2006;2(1):57–62. [PMC free article] [PubMed] [Google Scholar]
104. Borel JC, et al. Comorbidities and mortality in hypercapnic obese under domiciliary noninvasive ventilation. PLoS One. 2013;8(1):e52006. [PMC free article] [PubMed] [Google Scholar]
105. Sugerman HJ, et al. Gastric surgery for respiratory insufficiency of obesity. Chest. 1986;90(1):81–6. [PubMed] [Google Scholar]
106. Thomas PS, et al. Respiratory function in the morbidly obese before and after weight loss. Thorax. 1989;44(5):382–6. [PMC free article] [PubMed] [Google Scholar]
107. Vaughan RW, Cork RC, Hollander D. The effect of massive weight loss on arterial oxygenation and pulmonary function tests. Anesthesiology. 1981;54(4):325–8. [PubMed] [Google Scholar]
108. Weiner P, et al. Influence of excessive weight loss after gastroplasty for morbid obesity on respiratory muscle performance. Thorax. 1998;53(1):39–42. [PMC free article] [PubMed] [Google Scholar]
109. Boone KA, et al. Impact of Vertical Banded Gastroplasty on Respiratory Insufficiency of Severe Obesity. Obes Surg. 1996;6(6):454–458. [PubMed] [Google Scholar]
110. Dixon JB, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;308(11):1142–9. [PubMed] [Google Scholar]
111. Gloy VL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934. [PMC free article] [PubMed] [Google Scholar]
112. Sjostrom L, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52. [PubMed] [Google Scholar]
113. Sugerman HJ, et al. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr. 1992;55(2 Suppl):597S–601S. [PubMed] [Google Scholar]
114. Piper AJ, Grunstein RR. Current perspectives on the obesity hypoventilation syndrome. Curr Opin Pulm Med. 2007;13(6):490–6. [PubMed] [Google Scholar]
115. Lumachi F, et al. Hypoxemia and hypoventilation syndrome improvement after laparoscopic bariatric surgery in patients with morbid obesity. In Vivo. 2010;24(3):329–31. [PubMed] [Google Scholar]
116. De Cesare A, et al. Early and long-term clinical outcomes of bilio-intestinal diversion in morbidly obese patients. Surg Today. 2014;44(8):1424–33. [PubMed] [Google Scholar]
117. Marti-Valeri C, et al. Improvement of associated respiratory problems in morbidly obese patients after open Roux-en-Y gastric bypass. Obes Surg. 2007;17(8):1102–10. [PubMed] [Google Scholar]
118. Ashrafian H, et al. Metabolic surgery and obstructive sleep apnoea: the protective effects of bariatric procedures. Thorax. 2012;67(5):442–9. [PubMed] [Google Scholar]
119. Kim SH, et al. Evaluation of patients with sleep apnea after tracheotomy. Arch Otolaryngol Head Neck Surg. 1998;124(9):996–1000. [PubMed] [Google Scholar]
120. Sullivan CE, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862–5. [PubMed] [Google Scholar]
121. El Solh AA, Jaafar W. A comparative study of the complications of surgical tracheostomy in morbidly obese critically ill patients. Crit Care. 2007;11(1):R3. [PMC free article] [PubMed] [Google Scholar]
122. Teppema LJ, Dahan A. Acetazolamide and breathing. Does a clinical dose alter peripheral and central CO(2) sensitivity? Am J Respir Crit Care Med. 1999;160(5 Pt 1):1592–7. [PubMed] [Google Scholar]
123. Wagenaar M, et al. Comparison of acetazolamide and medroxyprogesterone as respiratory stimulants in hypercapnic patients with COPD. Chest. 2003;123(5):1450–9. [PubMed] [Google Scholar]
124. Kiwull-Schone HF, Teppema LJ, Kiwull PJ. Low-dose acetazolamide does affect respiratory muscle function in spontaneously breathing anesthetized rabbits. Am J Respir Crit Care Med. 2001;163(2):478–83. [PubMed] [Google Scholar]
125. van de Ven MJ, et al. Effects of acetazolamide and furosemide on ventilation and cerebral blood volume in normocapnic and hypercapnic patients with COPD. Chest. 2002;121(2):383–92. [PubMed] [Google Scholar]
126. Vos PJ, et al. Effects of chlormadinone acetate, acetazolamide and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease (COPD) Eur Respir J. 1994;7(5):850–5. [PubMed] [Google Scholar]
127. Swenson ER, Hughes JM. Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men. J Appl Physiol (1985) 1993;74(1):230–7. [PubMed] [Google Scholar]
128. Powers MA. Obesity hypoventilation syndrome: bicarbonate concentration and acetazolamide. Respir Care. 2010;55(11):1504–5. [PubMed] [Google Scholar]
129. Mason M, Welsh EJ, Smith I. Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2013;5 CD003002. [PubMed] [Google Scholar]
130. Parthasarathy S, Subramanian S, Quan SF. A Multicenter Prospective Comparative Effectiveness Study of the Effect of Physician Certification and Center Accreditation on Patient-Centered Outcomes in Obstructive Sleep Apnea. J Clin Sleep Med. 2014;10(3):1–7. [PMC free article] [PubMed] [Google Scholar]
